alexa Cancer Biomarkers: Clinical Research Review
ISSN: 2471-8556

Oncology & Cancer Case Reports
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

December 05-07, 2016 Philadelphia, USA

Ogbonna Shadrach Chidubem
All Saints University School of Medicine, Dominica
Posters & Accepted Abstracts: Oncol Cancer Case Rep
DOI: 10.4172/2471-8556.C1.003
Biomarker is usually molecular element that can be accurately measured as indicators of normal biological functioning. Because of this unique function and property, they have found wide application in disease diagnosis, prognosis, prediction and evaluation of treatment response. They have become an essential part of clinical medical practice and research. One area of clinical research where biomarkers have found wide and relevant application is in the area of cancer diagnosis and treatment. Cancer related incidences and deaths have continued to increase worldwide. A proper understanding of the clinical relevance of each biomarker will be very important not only for diagnosing these various cancers but also help in the choice of multiple therapeutic alternatives. Of the numerous biomarkers, few are useful for cancer diagnosis and monitoring. These include a broad range of compounds such as, lipids, sugars, nucleic acids, proteins, whole tumor cells found in the body fluids, and small metabolites, as well as cytogenetic and cytokinetic parameters. The application of biomarkers to cancer is leading the way because of the unique association of genomic changes in cancer cells with the disease process. Scientists have over the years carried out researches to discover and validate cancer biomarkers. Several promising biomarkers have been discovered, but not all validated for clinical use. This preliminary clinical research review of cancer biomarkers to date is therefore being presented to assess the stage of development, progress, success and application of the various cancer biomarkers discovered yet.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version